1 Comment

In my practice I have 1 patient in the past 5 years.

This paper may have more to do with an agenda to use Lutetium PSMA. Maybe more patients will receive docetaxel then be eligible for Pluvicto before the PSMAfore trial allows for us to use it before a taxane.

Expand full comment